Hayes Timothy
SEC Form 4 insider trading activity
Hayes Timothy has filed 6 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Oct 9, 2026.
On the most recent filing, Hayes Timothy is listed as Director at Health In Tech, Inc. Inside the rolling window, Hayes Timothy reported no open-market purchases and 3 open-market sales totaling $27K in HIT. The largest disclosed transaction in the window is a sale of 12,000 HIT shares on Sep 11, 2026, worth $11K.
Companies traded
Other insiders at HIT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$27K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hayes Timothy made?
Hayes Timothy has filed 6 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Hayes Timothy trade?
Hayes Timothy has filed SEC Form 4 disclosures for 1 company, including HIT.
When was Hayes Timothy's most recent SEC Form 4 filing?
Hayes Timothy's most recent SEC Form 4 filing on Tracefour is dated Oct 9, 2026.
What is Hayes Timothy's total buy and sell value in the current window?
Inside the rolling retention window, Hayes Timothy bought $0 and sold $27K based on SEC Form 4 filings.
What was Hayes Timothy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 12,000 HIT shares on 2026-09-11, worth $11K, per SEC Form 4 filings.